Clinical Trial Update: Universal Anti-Viral Vaccine for Healthy Elderly Adults [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of a universal antiviral vaccine for healthy elderly adults has completed, evaluating safety across multiple viral infections and related pneumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia
• Respiratory Distress Syndrome
• Respiratory Syncytial Virus Infection
• Viral Infections

Drugs mentioned

• Universal Antiviral Vaccine

Snippet

Sponsor: Mirror Biologics, Inc. | Conditions: Virus Diseases, Pneumonia | Phase 1, Phase 2 | Status: COMPLETED